working in the bioincubator and at TLS Foundation
RESEARCH FOUNDATION
TLS supports research activities in the Life Sciences and orphan diseases
OUR RESULTS
budget data at 31/12/2019
since 2007 and 84 in 2019
collaborations and licenses since 2007
active patents since 2007
211MILLION EUROSof financing generated and attracted by companies, research groups and TLS Foundation since 2007 (38 in 2019)
17MILLION EUROSof turnover by the incubated and affiliated companies and by the research groups in 2019
3.2MILLION EUROSof income from TLS incubation activities and services in 2019
Via Fiorentina 1 – Siena
Strada del Petriccio e Belriguardo, 35 - Siena
THE TLS FOUNDATION
Toscana Life Sciences is a non-profit organization active throughout the region in supporting research activities and promoting the creation of innovative companies in the Life Sciences field. Founded at the instigation of Tuscany’s principal university, clinical, industrial and financial institutions, the Foundation is based in Siena, in the historical “Torre Fiorentina” area, where Achille Sclavo founded the eponymous Istituto Sieroterapico e Vaccinogeno Toscano in 1904, and where important multinational vaccine companies now strategically choose to locate their primary research and development activities. An environment of excellence that is part of a regional panorama in which the Life Sciences play a strategic role.
OURPARTNERS
TLSA MULTIFACETED ORGANIZATION
BUSINESS INCUBATOR
An incubator that is unique on the national panorama for its facilitation of the business startup process in the Life Sciences sector
TECHNOLOGY TRANSFER FOR THE TUSCANY REGION
Responsible for implementing research valorization activities for the Tuscany Region through the UVaR office
MANAGER OF THE TUSCANY LIFE SCIENCES CLUSTER
Coordinator and manager of the activities of the Tuscany Life Sciences Cluster
COORDINATOR OF THE “TOSCANA PHARMA & DEVICE VALLEY” PROJECT
The know-how and experience of TLS in support of an ambitious project of the Tuscany Region
REPRESENTATIVE OF TUSCANY IN THE ALISEI CLUSTER
TLS represents the Tuscany Region in the national Life Sciences cluster ALISEI
ITS FOUNDATOR “New technologies for life”
TLS takes care of the administrative and organisational aspects of the training courses in the field of the industrial biotechnologies and medical devices.
OURSERVICES
Business development services
We help Life Sciences start-ups and companies to structure and ramp up their business project, offering support for business development, from writing a business plan to the search for investors. read more
Incubation services
The incubated companies have access to a package of general and consulting services for routine management and commercial development needs. read more
Protection of intellectual property
We help you evaluate the assets of your research project, protect them and valorize their results, providing advice regarding intellectual property and technology transfer. read more
Research services
TLS makes technological platforms and equipment for research available to companies, start-ups and external groups. read more
THE BIOINCUBATOR
The bioincubator is the natural habitat for the birth and development of new companies (start-ups and spin-offs) in the Life Sciences sector. A "home" where research groups and companies that are already active can also find spaces, technological facilities and services to grow and compete in the Life Sciences market. A dynamic environment with over 3000 square meters of laboratories in which to capitalize on ideas and construct valuable relationships.
JOIN THE BIOINCUBATOR
Joining the bioincubator is simple. Discover how we can help you give birth to your company or develop your research activities within our spaces. We operate in the following sectors: biotech, pharma, medical devices, nutraceuticals, cosmeceuticals and ICT applied to heathacare. You can apply for incubation or choose the TLS affiliation path to use our services.
UVAR
TLS collaborates in the management of the activities of the Office for the Valorization of Biomedical and Pharmaceutical Research (UVaR) at the Directorate General for Citizenship Rights and Social Cohesion of the Tuscany Region. The first experience of this type in Italy, UVaR offers support for the management and exploitation of research results in coordination with the region’s universities, graduate schools and university hospitals in order to structure a synergistic system that supports research and innovation in Tuscany.
distretto toscano
scienze della vita
TLS manages the activities of the regional cluster that aggregates all of the public and private subjects working in the following sectors in Tuscany: biotech, pharma, medical devices, nutraceuticals, cosmeceuticals and ICT applied to heathacare.
ITS VITA - “LIFE” TECHNICAL VOCATIONALSCHOOL
The Tuscany-based “New technologies for Life” Technical Vocational School [Istituto Tecnico Superiore (ITS) "Nuove tecnologie per la Vita"] trains specialized technicians in the chemical-pharmaceutical sector through two-year post-high school courses constructed on the basis of the needs and requirements of companies.
OURPROJECTS
COSME-AI4DIAG
AI4DIAg focuses on three technology areas (Image Processing, Medical Signal Analytics and Genomics) to develop and increase SME’s skills in the use and integration of Artificial Intelligence and Machine Learning algorithms in their solutions both from a technological and regulatory point of view.
ERC Advanced Grant OMVac
TLS is one of the beneficiaries of an Advanced Grant supported by the European Research Council to build a novel platform for the development of vaccines against infectious diseases and cancer.
ERC Advanced Grant VACCIBIOME
TLS is one of the beneficiaries of an Advanced Grant supported by the European Research Council to investigate the role of gut microbiome in determining the efficacy of cancer vaccines.
Monoclonal Antibody Discovery (MAD) LAB
The MAD Lab research team at TLS Foundation started activities in 2018 thanks to a 2.5 million euros ERC Advanced Grant focused on anti-microbialresistance and has grown quickly thanks to various funding sources received for tackling different health challenges
IDF SHARID
The project has the ambitious aim to conceptually allow the molecular prediction of diabetes type 2 and the response or resistance to molecular targeting interventions through the development of an innovative LOC (lab on chip) able to reveal important epigenotypes and rare genetic variations.
My First AIRC grant @Tumour Immunology Unit
This grant aims to support young researchers in establishing independent laboratories focused on the cutting-edge oncology research. Specifically, we are interested in studying one of the most frequent tumours of B lymphocytes, B-cell chronic lymphocytic leukemia (CLL).
Regions4PerMed
Toscana Life Sciences will coordinate the project in partnership with excellent actors from Germany, Spain, Polland and with the Fondazione Regionale per la Ricerca Biomedica (Lombardy Region), in order to elaborate guidelines supporting future research and innovation programmes concerning Personalised Medicine.
BORNTOGEtTHERe
Despite progress in high risk maternity management, Cerebral Palsy (CP) is the most common cause of physical disability in infants.
SINO-EU‐PERMED – “WIDENING SINO‐EU POLICY AND RESEARCH COOPERATION IN PERSONALISED MEDICINE”
The health systems’ transformation from reactive treatment models to predictive and preventive systems, so as the personalised medicine paradigm implementation, requires cooperation and coordination among different actors, not only at European and Community level, with the aim of building an integrated action plan to foster the innovation in this field.
DISSEMINATING
SCIENCE AND INNOVATION
Introducing young people to the world of research, science, innovation and business culture. With this objective, TLS has launched numerous initiatives to communicate science in high schools and promote entrepreneurship, both through its own projects and in collaboration with other public and private partners.
OUR COMMITMENT TO
ORPHAN DISEASES
TLS is committed to supporting the advancement of research in the field of orphan diseases, working as a link between basic research and its industrial application in the biomedical and pharmaceutical fields.
